JP2024512497A5 - - Google Patents
Info
- Publication number
- JP2024512497A5 JP2024512497A5 JP2023557369A JP2023557369A JP2024512497A5 JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5 JP 2023557369 A JP2023557369 A JP 2023557369A JP 2023557369 A JP2023557369 A JP 2023557369A JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- independently selected
- compound according
- sulfur
- nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162487P | 2021-03-17 | 2021-03-17 | |
| US63/162,487 | 2021-03-17 | ||
| PCT/US2022/020491 WO2022197763A1 (en) | 2021-03-17 | 2022-03-16 | Inhibitors of plasma kallikrein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512497A JP2024512497A (ja) | 2024-03-19 |
| JP2024512497A5 true JP2024512497A5 (cg-RX-API-DMAC10.html) | 2025-03-24 |
Family
ID=81326196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557369A Pending JP2024512497A (ja) | 2021-03-17 | 2022-03-16 | 血漿カリクレインの阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240226106A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4308229A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024512497A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117396469A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022197763A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112135825A (zh) | 2018-03-13 | 2020-12-25 | 夏尔人类遗传性治疗公司 | 血浆激肽释放酶抑制剂及其用途 |
| CN114728962B (zh) | 2019-09-18 | 2025-09-19 | 武田药品工业有限公司 | 血浆激肽释放酶抑制剂及其用途 |
| WO2021055589A1 (en) | 2019-09-18 | 2021-03-25 | Shire Human Genetic Therapies, Inc. | Heteroaryl plasma kallikrein inhibitors |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| KR20020088406A (ko) * | 1999-09-17 | 2002-11-27 | 애보트 게엠베하 운트 콤파니 카게 | 치료제로서의 피라졸로피리미딘 |
| AU3950802A (en) * | 2000-12-07 | 2002-06-18 | Cv Therapeutics Inc | Abca-1 elevating compounds |
| TW201103904A (en) * | 2009-06-11 | 2011-02-01 | Hoffmann La Roche | Janus kinase inhibitor compounds and methods |
| WO2014074715A1 (en) * | 2012-11-07 | 2014-05-15 | Genentech, Inc. | Cyclopropyl amide derivatives |
| JP2017500287A (ja) * | 2013-11-06 | 2017-01-05 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Gsk−3阻害剤として有用な置換ピリジン誘導体 |
| WO2015164308A1 (en) * | 2014-04-22 | 2015-10-29 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| EP3578541B1 (en) * | 2015-04-17 | 2025-05-28 | Corteva Agriscience LLC | Compositions comprising molecules having pesticidal utility, and processes related thereto |
| CN107849026B (zh) * | 2015-07-29 | 2021-01-01 | 百时美施贵宝公司 | 携带烷基或环烷基p2′部分的因子xia大环抑制剂 |
| MX2019010302A (es) * | 2017-03-30 | 2019-11-21 | Hoffmann La Roche | Isoquinolinas como inhibidores de hpk1. |
| CN110678466B (zh) * | 2017-03-30 | 2023-01-31 | 豪夫迈·罗氏有限公司 | 作为hpk1抑制剂的二氮杂萘类 |
| MY202167A (en) * | 2017-11-21 | 2024-04-12 | Bristol Myers Squibb Co | Sulfone pyridine alkyl amide-substituted heteroaryl compounds |
| CN112135825A (zh) | 2018-03-13 | 2020-12-25 | 夏尔人类遗传性治疗公司 | 血浆激肽释放酶抑制剂及其用途 |
| WO2021004535A1 (en) * | 2019-07-11 | 2021-01-14 | Nanjing Zhengxiang Pharmaceuticals Co., Ltd. | Cinnolines as inhibitors of hpk 1 |
| CN114605401B (zh) * | 2020-04-28 | 2023-08-22 | 江南大学 | 一类含氧五元杂环化合物、合成方法、药物组合物及用途 |
-
2022
- 2022-03-16 US US18/550,504 patent/US20240226106A1/en active Pending
- 2022-03-16 WO PCT/US2022/020491 patent/WO2022197763A1/en not_active Ceased
- 2022-03-16 CN CN202280033915.5A patent/CN117396469A/zh active Pending
- 2022-03-16 JP JP2023557369A patent/JP2024512497A/ja active Pending
- 2022-03-16 EP EP22714697.4A patent/EP4308229A1/en active Pending